ResMed beats quarterly profit estimates on strong demand for its sleep apnea devicesReuters • 10/24/24
ResMed Adds To Its Recent Sprint, Shrugging Off Worries Tied To Obesity DrugsInvestors Business Daily • 10/24/24
Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 10/21/24
RMD Stock Likely to Gain From Enhanced Digital Sleep Health SolutionsZacks Investment Research • 10/01/24
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder ReturnsGlobeNewsWire • 09/30/24
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep HealthGlobeNewsWire • 09/30/24
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep HealthGlobeNewsWire • 09/30/24
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep HealthGlobeNewsWire • 09/30/24
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep HealthGlobeNewsWire • 09/30/24
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of SafetySeeking Alpha • 09/19/24
S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten DemandInvestopedia • 09/18/24
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock ExchangeGlobeNewsWire • 09/10/24
United States Sleep Disorders Treatment Market 2024-2028, with Profiles of Better Night, Koala Centers, Marshall Medical Centers, Novasom, ResMed, Respironics, Sleep Holdings, SleepMed and MoreGlobeNewsWire • 09/04/24